Research and analysis

Novel benzodiazepines: prevalence and harms in the UK

This report examines the evidence of prevalence and harms in the UK of several novel benzodiazepines and provides advice to the government.

• From: Advisory Council on the Misuse of Drugs
• Published: 29 April 2020
• Last updated: 16 November 2020 — See all updates

Documents

ACMD report: a review of the evidence of use and harms of novel benzodiazepines

PDF, 603 KB, 44 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

ACMD letter to the Home Secretary: a review of the evidence of use and harms of novel benzodiazepines

PDF, 53.2 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Addendum to ACMD’s report on novel benzodiazepines

HTML

Details

This self-commissioned review follows an ACMD report published in 2016, which recommended 16 benzodiazepines for control under Class C of the Misuse of Drugs Act 1971 and Schedule 1 of the Misuse of Drugs Regulations 2001.

Since then, several novel benzodiazepines have been identified in drugs seizures across Europe. Prompted by concerns of the abuse potential of these substances the ACMD have conducted a review to assess the available evidence on prevalence and harms of 13 novel benzodiazepines, to identify those that warrant further legislative control.

We are aware these publications may have accessibility issues. We are reviewing them so that we can fix these.

Read more about our accessible documents policy.

Published 29 April 2020
Last updated 16 November 2020 + show all updates

1. 16 November 2020

   Addendum to novel benzodiazepines report November 2020 added.

2. 29 April 2020

   First published.